Wing Hong Seto | Health Professions | Best Researcher Award

Prof. Wing Hong Seto | Health Professions | Best Researcher Award

Prof. Wing Hong Seto, WHO Collaborating Centre for Infectious Diseases Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong

Dr. Seto Wing Hong is a globally acclaimed expert in infection control and epidemiology. He serves as Co-Director of the WHO Collaborating Centre for Infectious Disease Epidemiology and Control at the University of Hong Kong. With honorary and leadership roles across Asia-Pacific and international institutions, Dr. Seto is a trusted voice in pandemic response, hospital safety, and microbial science. A specialist in clinical microbiology, he has contributed significantly to WHO's COVID-19 response strategies. His distinguished career includes key roles such as Chief Infection Control Officer of the Hospital Authority in Hong Kong, and professor-level appointments in China, Australia, and the U.S. Dr. Seto’s work has been recognized through numerous prestigious awards, including the Bronze and Silver Bauhinia Stars. He continues to shape infection control policy, research, and clinical best practices globally. His dedication exemplifies leadership in the health professions at the highest level.

Professional Profile

Scopus

orcid

Evaluation for the β€œResearch for Best Researcher Award” – Dr. Seto Wing Hong

Summary of Suitability:

Dr. Seto Wing Hong stands out as an exemplary candidate for the Research for Best Researcher Award, bringing an unmatched depth of experience, expertise, and dedication to the field of infectious disease epidemiology and control. With a career spanning over four decades, Dr. Seto has significantly contributed to advancing global infection prevention practices, clinical microbiology, and public health policy. His current leadership as Co-Director of the WHO Collaborating Centre for Infectious Disease Epidemiology and Control at the University of Hong Kong positions him at the forefront of research and policy implementation in pandemic preparedness, infection control, and healthcare safety.

He has held numerous high-impact roles across national and international institutions, including serving as an expert member in several WHO advisory panels related to COVID-19, infection prevention, and public health emergencies. This not only highlights his research influence but also his global leadership and trusted advisory role in shaping real-time public health strategies. His previous roles within the Hospital Authority of Hong Kong, such as Chief Infection Control Officer and Chief of Service in Microbiology, underscore his operational experience in translating research into practiceβ€”especially during critical periods such as the SARS outbreak and COVID-19 pandemic.

Education 

Dr. Seto Wing Hong earned his MBBS in 1972, followed by MRCP(UK) and MRCPI in 1981. He furthered his credentials with MRCPath (1984) and FRCPath (1997). He is a Founding Fellow of both FHKCPath (1992) and FHKAM (Pathology) [1993], reflecting his pivotal role in establishing professional standards in pathology in Hong Kong. In 1996, he obtained American Board Certification in Healthcare Quality (CPHQ). His academic excellence was supplemented by advanced training in infection control at CDC Atlanta (1985) and patient safety leadership programs in Chicago (1994) and Department of Veterans Affairs, USA (2002). Clinical attachments at prestigious institutions such as St. Thomas' Hospital (UK) and Stanford University expanded his global perspective. His educational foundation has been instrumental in his thought leadership across clinical microbiology and hospital infection control, helping train generations of professionals across continents.

Professional Experience

Dr. Seto Wing Hong has held transformative roles in public health and clinical governance. He served as Chief Infection Control Officer and Cluster Director of Quality & Risk Management at Queen Mary Hospital and the Hong Kong West Cluster under the Hospital Authority. He also served as Chief of Service in Microbiology, shaping hospital-wide infection control policies. Internationally, he is Co-Director of the WHO Collaborating Centre for Infectious Disease Epidemiology and Control and an Expert Member in several WHO committees. In academia, Dr. Seto is a Clinical Professor (Hon) at HKU and has held visiting professorships across China and Australia. He is also a Medical Advisor to private hospitals in Hong Kong. His consultancy roles in the People’s Liberation Army (PRC) and at UNSW, Australia, reflect his wide-ranging influence. His combined hospital, academic, and global advisory experience marks him as a pioneer in health systems improvement and infectious disease control.

Awards and Recognition

Dr. Seto Wing Hong has been widely recognized for his groundbreaking contributions. He received the Best Paper Award and Research Sponsorships from the Hospital Authority in 1994. He led and contributed to Outstanding Team Awards in 1999 and 2000, highlighting his collaborative excellence. For his heroic leadership during SARS, he was awarded the Special SARS Commendation Medal and the Hong Kong West Gold Badge in 2003. These honors were followed by the Bronze Bauhinia Star (2004) and Silver Bauhinia Star (2011), prestigious honors from the Hong Kong SAR Government. In 2012, he was recognized as a Distinguished International Fellow of the Infection Control Association of China. His affiliations with the F1000Prime Faculty since 2014 further validate his scientific impact. These accolades reflect Dr. Seto’s unparalleled dedication to public health, quality care, and infectious disease prevention.

Research Skill On Health Professions

Dr. Seto Wing Hong is a world leader in infection prevention, epidemiology, and clinical microbiology. His research focuses on nosocomial infections, hand hygiene, and pandemic preparedness, having contributed extensively during SARS and COVID-19. As an expert member of multiple WHO advisory panels, his insights shape global infection control strategies. His scientific training is backed by work in high-risk environments, contributing to hospital design, airflow systems, and engineering controls in health settings. Dr. Seto integrates clinical insight with systems thinking, applying quality improvement (CQI) tools for enhanced safety. His work spans microbiological diagnostics, healthcare-associated infections (HAIs), and environmental hygiene innovations. He is skilled in translating evidence into policy, making him an asset for health ministries, hospitals, and international bodies. His mentorship has developed leaders in infection control across Asia-Pacific. A systems thinker and evidence-based strategist, Dr. Seto stands at the forefront of health research excellence.

  Publication Top Notes

1. Surgical implant sterilization in the Asia–Pacific region: A survey of current practices
2. Effective risk management strategy prevented severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission in three private hospitals in Hong Kong throughout the pandemic
  • Authors: Wing Hong Seto, Patricia T.Y. Ching, Andy M.W. Leung, August W.M. Fok, Shing Cheung, Eddie W.Y. Cheung, Clara D.K. Kwok, Kenneth H.L. Tsang, Benjamin J. Cowling

  • DOI: 10.1017/ice.2021.500

  • Year: 2022

3. Activity of ceftolozane/tazobactam against Gram-negative isolates among different infections in Hong Kong: SMART 2017–2019
  • Authors: James A. Karlowsky, Sibylle H. Lob, Aaron Khan, Wei-Ting Chen, Patrick C.Y. Woo, Wing Hong Seto, Margaret Ip, Stanley Leung, Queenie W.-L. Wong, Rene W.Y. Chau, et al.

  • DOI: 10.1099/jmm.0.001487

  • Year: 2022

4. Author Correction: Respiratory virus shedding in exhaled breath and efficacy of face masks
  • Authors: Leung N.H.L., Chu D.K.W., Shiu E.Y.C., Chan K.-H., McDevitt J.J., Hau B.J.P., Yen H.-L., Li Y., Ip D.K.M., Peiris J.S.M., et al.

  • DOI: 10.1038/s41591-020-0946-9

  • Year: 2020

5. Erratum: Use of medical face masks versus particulate respirators...
6. Respiratory virus shedding in exhaled breath and efficacy of face masks
  • Authors: Leung N.H.L., Chu D.K.W., Shiu E.Y.C., Chan K.-H., McDevitt J.J., Hau B.J.P., Yen H.-L., Li Y., Ip D.K.M., Peiris J.S.M., et al.

  • DOI: 10.1038/s41591-020-0843-2

  • Year: 2020

7. Use of medical face masks versus particulate respirators...
  • Authors: Conly J., Seto W.H., Pittet D., Holmes A., Chu M., Hunter P.R., Cookson B., et al.

  • DOI: 10.1186/s13756-020-00779-6

  • Year: 2020

8. Are reusable blood collection tube holders the culprit for nosocomial hepatitis C virus transmission?
  • Authors: Tsang D.N.C., Ip M., Chan P.K.S., Ching P.T.Y., Lam H.S., Seto W.H.

  • DOI: 10.1017/ice.2018.302

  • Year: 2019

9. Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3)
  • Authors: Zingg W., Storr J., Park B.J., Jernigan J.A., Harbarth S., Grayson M.L., Tacconelli E., Allegranzi B., Cardo D., Pittet D., et al.

  • DOI: 10.1186/s13756-019-0528-0

  • Year: 2019

10. Determinants of methicillin-resistant Staphylococcus aureus (MRSA) prevalence in the Asia-Pacific region
  • Authors: Lim W.W., Wu P., Bond H.S., Wong J.Y., Ni K., Seto W.H., Jit M., Cowling B.J.

  • DOI: 10.1016/j.jgar.2018.08.014

  • Year: 2019

Mei-Fang Tan | Veterinary Science | Best Researcher Award

Dr. Mei-Fang Tan | Veterinary Science | Best Researcher Award

πŸ‘€ Dr. Mei-Fang Tan, Institute of Animal Husbandry and Veterinary Science, Jiangxi Academy of Agricultural Sciences, China

Dr. Mei-Fang Tan, an Associate Researcher at the Institute of Animal Husbandry and Veterinary Science, Jiangxi Academy of Agricultural Sciences, is a leading expert in veterinary epidemiology. With a Ph.D. in Preventive Veterinary Medicine from Huazhong Agricultural University (2016), she specializes in the prevention and control of bacterial diseases in livestock, focusing on drug resistance monitoring in swine and poultry. Her research has significantly advanced veterinary medicine, particularly in understanding the pathogenic mechanisms of Avian pathogenic Escherichia coli (APEC) and Streptococcus suis. Dr. Tan has collected over 1,000 samples from diseased animals and isolated over 600 pathogenic strains. Her ongoing studies in the molecular characterization of these pathogens contribute to more effective disease management and vaccine development, marking her as a key contributor to veterinary science in China.

Professional Profile

Scopus

🌟 Suitability for Best researcher Award

Mei-Fang Tan demonstrates a strong and impactful profile for the Research for Best Researcher Award, particularly in the field of veterinary medicine and animal health. Her academic background, with a Ph.D. in Preventive Veterinary Medicine, laid the foundation for her significant contributions in epidemiology and drug resistance monitoring in livestock and poultry farming. Over the years, Dr. Tan has contributed significantly to the understanding and management of bacterial diseases in animal populations, which is critical for the health of both the animals and the broader agricultural community.

Research Excellence and Impact: Dr. Tan’s research on the pathogenic mechanisms of bacterial diseases, including Avian pathogenic Escherichia coli (APEC) and Streptococcus suis, has led to valuable insights that aid in the prevention and control of these diseases. Her innovative work has resulted in the isolation of over 600 pathogenic bacterial strains from swine and poultry flocks, which has directly contributed to her ongoing studies aimed at addressing antimicrobial resistanceβ€”a key global concern in veterinary medicine.

πŸŽ“  Education 

Dr. Mei-Fang Tan obtained her Ph.D. in Preventive Veterinary Medicine from Huazhong Agricultural University in 2016, where she focused on infectious disease epidemiology. Her academic journey began with a Bachelor’s and Master’s degree in Veterinary Medicine from the same institution, where she gained extensive knowledge in clinical veterinary practice and microbiology. Throughout her education, Dr. Tan developed a passion for epidemiology and veterinary public health, which led her to pursue in-depth research in the control of bacterial diseases. Her dissertation, which centered on Escherichia coli and Streptococcus suis in swine and poultry, was well-received for its contribution to improving disease prevention strategies. Dr. Tan’s education has equipped her with the skills to tackle the growing concerns of antimicrobial resistance and bacterial pathogens in agriculture, especially within swine and poultry farms in Jiangxi Province, China.

πŸ’Ό Professional Experience 

Dr. Mei-Fang Tan has worked at the Institute of Animal Husbandry and Veterinary Science, Jiangxi Academy of Agricultural Sciences, since 2016. As an Associate Researcher, she specializes in the surveillance and control of bacterial diseases, with a focus on antimicrobial resistance in swine and poultry. Over the years, Dr. Tan has led several critical projects funded by the National Natural Science Foundation of China and Jiangxi Provincial Natural Science Foundation, focusing on drug resistance monitoring and molecular characterization of pathogens. Her work has contributed significantly to understanding the pathogenic mechanisms of important bacteria like Escherichia coli and Streptococcus suis, paving the way for new vaccines and prevention strategies. She has also established a robust network of collaborations with other research institutions and veterinary professionals to combat emerging infectious diseases in livestock, strengthening veterinary science practices in China and beyond.

 πŸ… Awards and Recognition

Dr. Mei-Fang Tan’s work has earned her recognition in veterinary science and research. She has been awarded multiple grants from prestigious institutions like the National Natural Science Foundation of China and the Jiangxi Provincial Natural Science Foundation. Her groundbreaking research has resulted in several publications in leading scientific journals such as Poultry Science and Frontiers in Cellular and Infection Microbiology. Dr. Tan has been instrumental in developing polyvalent inactivated vaccines against Escherichia coli, which are expected to revolutionize disease prevention in poultry. Her contributions to animal health, particularly in antimicrobial resistance surveillance and bacterial pathogen monitoring, have placed her at the forefront of veterinary epidemiology. Dr. Tan’s work continues to influence policy changes in livestock health management, and her research has garnered significant international attention.

🌍 Research Skills On Veterinary Science

Dr. Mei-Fang Tan’s research expertise lies in epidemiology, bacteriology, and antimicrobial resistance in livestock. She employs cutting-edge techniques such as whole-genome sequencing to analyze bacterial pathogens and monitor drug resistance profiles in swine and poultry. Dr. Tan’s proficiency in molecular characterization has enabled her to identify new pathogenic strains of Escherichia coli and Streptococcus suis, and her innovative work in vaccine development is transforming the prevention of bacterial diseases in agriculture. Her research is data-driven, utilizing advanced microbiological techniques, bioinformatics, and statistical analysis to provide insights into the prevalence and spread of infectious diseases. Additionally, Dr. Tan’s interdisciplinary approach integrates veterinary science with molecular biology, allowing her to create practical solutions for animal health challenges. Her work bridges the gap between basic research and clinical application, offering sustainable solutions for disease control in livestock.

πŸ“– Publication Top Notes

  • Alteration of gut microbiome in goslings infected with goose astrovirus
    Authors: Li, H., Su, Q., Fu, D., Wei, Q., Guo, X.
    Citation: Poultry Science, 2024, 103(8), 103869
  • Pathogenicity and identification of host adaptation genes of the avian pathogenic Escherichia coli O145 in duck
    Authors: Tan, M.-F., Tan, J., Fang, S.-P., Lin, C., Huang, J.-N.
    Citation: Frontiers in Cellular and Infection Microbiology, 2024, 14, 1453907
  • Epidemiological monitoring and genetic variation analysis of pathogens associated with porcine viral diarrhea in southern China from 2021 to 2023
    Authors: Zhang, F., Luo, Y., Lin, C., Xiong, L., Ji, H.
    Citation: Frontiers in Microbiology, 2024, 15, 1303915
  • Correction to: Rapid detection of goose astrovirus genotypes 2 using real-time reverse transcription recombinase polymerase amplification (BMC Veterinary Research, 2023, 19, 1, (232), 10.1186/s12917-023-03790-2)
    Authors: Li, H., Zhu, Y., Wan, C., Kang, Z., Guo, X.
    Citation: BMC Veterinary Research, 2023, 19(1), 245
  • Rapid detection of goose astrovirus genotypes 2 using real-time reverse transcription recombinase polymerase amplification
    Authors: Li, H., Zhu, Y., Wan, C., Kang, Z., Guo, X.
    Citation: BMC Veterinary Research, 2023, 19(1), 232
  • Prevalence and antimicrobial resistance profile of bacterial pathogens isolated from poultry in Jiangxi Province, China from 2020 to 2022
    Authors: Tan, M.-F., Li, H.-Q., Yang, Q., Li, N., Kang, Z.-F.
    Citation: Poultry Science, 2023, 102(8), 102830
  • Rapid diagnosis of different goose astrovirus genotypes with Taqman-based duplex real-time quantitative PCR
    Authors: Li, H., Kang, Z., Wan, C., Su, Q., Guo, X.
    Citation: Poultry Science, 2023, 102(7), 102730
  • Rapid diagnosis of duck Tembusu virus and goose astrovirus with TaqMan-based duplex real-time PCR
    Authors: Li, H., Wan, C., Wang, Z., Kang, Z., Guo, X.
    Citation: Frontiers in Microbiology, 2023, 14, 1146241
  • Exogenous glycogen utilization effects the transcriptome and pathogenicity of Streptococcus suis serotype 2
    Authors: Tan, M.-F., Tan, J., Zhang, F.-F., Zeng, Y.-B., Yang, Q.
    Citation: Frontiers in Cellular and Infection Microbiology, 2022, 12, 938286
  • Isolation and phylogenetic analysis of goose astrovirus type 1 from goslings with gout in Jiangxi province, China
    Authors: Zhang, F., Li, H., Wei, Q., Tan, M., Kang, Z.
    Citation: Poultry Science, 2022, 101(7), 101800